For almost two-thirds of his life, Nick Jonas has lived with a chronic condition — type 1 diabetes. The Jonas Brothers-famed ...
IRELAND’S first recipient of a simultaneous kidney–pancreas transplant has passed away, with tributes pouring in for the ...
The managing director of Novo Nordisk India on Ozempic’s delayed launch in India, leading the fight against diabetes and ...
AIIMS Delhi reports metabolic surgery helps many with uncontrolled Type-2 diabetes; 30% stopped meds. Early intervention ...
Doctors typically begin patients on 0.25 mg once a week for the first month. After the introductory phase, the dosage ...
Thje star previously been very open about her use of weight loss jabs on the programme, and has now dropped four dress sizes ...
GLP-1 weight-loss injections are increasingly misused without proper medical guidance in India. Experts warn this trend leads ...
After 12 weeks of treatment, the 4 mg and 6 mg mazdutide groups achieved reductions in BMI from baseline of 8.
Rhythm Pharmaceuticals is rated a Buy, driven by progress in HO, PWS, and oral MC4R agonists. Click here to read my latest ...
The weekly injection was approved by the US Food and Drug Administration in 2017 for people with type 2 diabetes.
After 12 weeks of treatment, the 4 mg and 6 mg mazdutide groups achieved reductions in BMI from baseline of 8.78% and 10.99%, respectively, with corresponding body ...
VANCOUVER, BC / ACCESS Newswire / December 11, 2025 / LIR Life Sciences Corp. ("LIR" or the "Company") announces that it has filed a provisional patent application intended to cover a needle-free ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results